Australia Patient Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The australia patient monitoring market size was valued at USD 0.85 billion in 2025 and estimated to grow from USD 0.92 billion in 2026 to reach USD 1.35 billion by 2031, at a CAGR of 7.98% during the forecast period (2026-2031). This report is Segmented by Product Type (Multi-Parameter Monitors, Cardiac Monitoring Devices, and More), Modality (Bedside/Stationary, Portable/Compact, and More), End User (Hospitals & Public Health Services, Private Hospitals & Day Surgery Centers, and More), Application (Cardiology, Neurology, and More). The Market Forecasts are Provided in Terms of Value (USD).

Australia Patient Monitoring Market Trends and Insights

Rising burden of chronic diseases & aging population

Diabetes mortality among Indigenous Australians is 4.4 times higher than for non-Indigenous peers, intensifying demand for continuous glucose, cardiac and wound-healing surveillance. Federal investment of USD 50 million in a total artificial heart and USD 3 billion in chronic-wound management highlights cardiovascular priorities. Smart wound patches from RMIT detect inflammatory markers in real time for roughly 500,000 chronic-wound cases annually. Short-Term Restorative Care pilots preserved 99% of client independence, demonstrating technology’s cost-avoidance potential for elder care. Population aging therefore amplifies needs for predictive analytics that pre-empt emergency admissions.

Expansion of telehealth reimbursement & government digital-health initiatives

Permanent Medicare telehealth items and triple bulk-billing incentives for vulnerable citizens create durable revenue for remote patient monitoring services. Tasmania’s Care@home extension shows state-level scaling of infection surveillance with around-the-clock clinician oversight. The National Healthcare Interoperability Plan has delivered one-third of its milestones, upgrading My Health Record so device data flows seamlessly across locations. A USD 3.5 billion federal allocation to triple bulk-billing incentives further pushes providers toward connected care and away from on-site consults.

High device cost & limited private reimbursement

Continuous glucose monitors and premium implantables remain expensive, especially for Indigenous patients with limited private cover. Modified Monash upgrades in 2025 raised bulk-billing rates in 34 regional towns, yet out-of-pocket device costs persist. Surveys show 80% of rural adults are digitally engaged but cite price and product complexity as leading adoption barriers. Private insurance seldom covers home-use monitoring hardware, stalling chronic-disease programs outside hospital walls.

Other drivers and restraints analyzed in the detailed report include:

• Rapid adoption of IoT-enabled wireless & wearable monitors
• Hospital-at-home & shift toward home-healthcare services
• Increasing cybersecurity & data-privacy compliance costs

Segment Analysis

Multiparameter monitors contributed 32.84% to the Australia patient monitoring market size in 2025 thanks to plug-and-play compatibility with electronic health records and rapid display of ECG, SpO₂ and NIBP on a single screen. Remote patient monitoring kits will outpace all peers at an 8.05% CAGR by bundling Bluetooth wearables, AI triage engines and Medicare-reimbursable data services. Cardiac lines strengthen as BIOMONITOR IV delivers 86% nuisance-alarm reduction, elevating clinician trust in implantable loop recorders.

Hemodynamic platforms consolidate under BD’s USD 4.2 billion deal for Edwards’ Critical Care group, creating an advanced waveform analysis leader with cloud-ready integration. Fetal and neonatal innovators such as VitalTrace use real-time lactate to cut emergency C-sections in half. Respiratory and neuro lines now embed edge AI that flags apnea or neurologic decline seconds after onset. Wearable monitors inherit smartphone design cues yet comply with TGA’s unique-device-identifier rules, bridging consumer ergonomics and hospital governance across the Australia patient monitoring market.

Bedside systems retained 49.35% of Australia patient monitoring market share in 2025 because ICU workflows rely on trusted central stations. Wearable and patch monitors, however, advance at a 9.01% CAGR as patients demand untethered mobility and clinicians see earlier ambulation shorten average length of stay. Portable devices straddle step-down wards, slashing unplanned ICU returns by relaying spot-check vitals every two minutes versus manual four-hour intervals.

Implantable sensors such as Abbott’s AVEIR leadless pacemaker now include conduction-system pacing, widening therapeutic reach. Satellite-backed data links push wearable telemetry to cattle stations and mining camps, reflecting government dual-use space-industry strategy. Regulatory mutual recognition for FDA-cleared hardware speeds upgrades, letting providers abandon 3G-era boxes without repeating full conformity assessments.

Complete Report Scope:

• By Product Type (Value, AUD mn)
  • Multi-parameter Monitors
  • Cardiac Monitoring Devices (ECG, Holter, MCT)
  • Hemodynamic Monitoring Devices
  • Fetal & Neonatal Monitors
  • Neuro Monitoring Devices
  • Respiratory Monitoring Devices
  • Remote Patient Monitoring Kits & Platforms
  • Vital Signs Monitors
  • Wearable Patient Monitors
• By Modality
  • Bedside / Stationary
  • Portable / Compact
  • Wearable / Patch
  • Implantable Sensors
• By End User
  • Hospitals & Public Health Services
  • Private Hospitals & Day Surgery Centers
  • Home Healthcare & Aged-Care Facilities
  • Ambulatory Care & GP Clinics
  • Telehealth Providers
• By Application
  • Cardiology
  • Neurology
  • Respiratory Care
  • Critical Care & ICU
  • Chronic Disease Management (Diabetes, Hypertension, COPD)
  • Perioperative & Anesthesia Monitoring
  • Post-Acute & Rehabilitation
• By Technology
  • Wired
  • Wireless (Bluetooth, Wi-Fi)
  • Cloud-connected / AI Analytics

List of Companies Covered in this Report:

• Koninklijke Philips
• GE Healthcare
• Medtronic
• Resmed
• Abbott Laboratories
• Siemens Healthineers
• Mindray
• Nihon Kohden
• Masimo
• Dragerwerk
• Baxter International Inc. (Hillrom / Welch Allyn)
• Compumedics
• Honeywell International (Health Solutions)
• iHealth Labs
• Teladoc Health
• Propell Health
• Apple
• Fitbit LLC (Google)
• Cochlear
• Nanosonics Limited

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support